|
FDA Comes Down on Contamination Risks at Genentech Avastin Plant
Genentech may need to tune up manufacturing practices at a San Francisco, Calif., plant that makes cancer drug Avastin.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives